EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation-Reference-Cited by-同舟云学术

EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation

Published:2009-03-16 Issue:13 Volume:106 Page:5324-5329
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Richter G. H. S.,Plehm S.,Fasan A.,Rossler S.,Unland R.,Bennani-Baiti I. M.,Hotfilder M.,Lowel D.,von Luettichau I.,Mossbrugger I.,Quintanilla-Martinez L.,Kovar H.,Staege M. S.,Muller-Tidow C.,Burdach S.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference39 articles.

1. DNA Microarrays Reveal Relationship of Ewing Family Tumors to Both Endothelial and Fetal Neural Crest-Derived Cells and Define Novel Targets

2. Expression of theEWS/FLI-1Oncogene in Murine Primary Bone-Derived Cells Results in EWS/FLI-1–Dependent, Ewing Sarcoma–Like Tumors

3. Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells

4. Mesenchymal Stem Cell Features of Ewing Tumors

Cited by 248 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas;Frontiers in Oncology;2024-07-18

2. Pharmacological targeting of the cancer epigenome;Nature Cancer;2024-06-27

3. Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases;Discover Oncology;2024-06-18

4. Unlocking epigenetics for precision treatment of Ewing's sarcoma;CHINESE J CANCER RES;2024

5. EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21) FUS::ERG gene fusion;2024-05-17